Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Altimmune, Inc.

NASDAQ: ALT · Life Sciences · 8 alerts · CIK 1326190

Share price
$1.56Close, Nov 16
Market cap
$304M
Shares outstanding
194.59MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Altimmune, Inc. filings on SEC EDGAR ↗

8:16 AM ET 8-K
Leadership Change

Altimmune Leadership Change

Altimmune appointed Peter Greenleaf and Alex Howarth to its Board of Directors effective November 2, 2026, increasing the board size to eleven. As part of a planned transition, directors John M. Gill, Mitchel Sayare, and Klaus O. Schafer will retire at the 2027 Annual Meeting. The new directors will receive an annual cash retainer of $40,000 and initial stock options for 160,000 shares each.

7:04 AM ET 8-K
Leadership Change

Altimmune Leadership Change

Altimmune, Inc. appointed Richard Menziuso as Vice President, Global Controller and Principal Accounting Officer, effective September 29, 2026. Mr. Menziuso joins from Centessa Pharmaceuticals and succeeds Gregory Weaver in the Principal Accounting Officer role, though Weaver remains the company's Chief Financial Officer.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.